Wells Fargo & Co. started coverage on shares of Intuitive Surgical Inc. (NASDAQ:ISRG) in a research report sent to investors on Thursday. The brokerage issued an outperform rating on the stock.

A number of other research analysts have also weighed in on ISRG. Leerink Swann reaffirmed an outperform rating and issued a $780.00 price objective on shares of Intuitive Surgical in a research note on Monday, September 19th. Northland Securities lowered shares of Intuitive Surgical from a market perform rating to an under perform rating and set a $600.00 price objective on the stock. in a research note on Thursday, July 21st. Canaccord Genuity raised their price objective on shares of Intuitive Surgical from $700.00 to $750.00 and gave the company a buy rating in a research note on Wednesday, July 20th. Bank of America Corp. reaffirmed a buy rating on shares of Intuitive Surgical in a research note on Wednesday, June 22nd. Finally, Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $700.00 to $800.00 and gave the company a buy rating in a research note on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the stock. Intuitive Surgical currently has a consensus rating of Buy and an average target price of $701.42.

Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 0.137% during mid-day trading on Thursday, hitting $714.415. 71,138 shares of the company traded hands. The firm has a 50-day moving average of $700.61 and a 200-day moving average of $662.91. Intuitive Surgical has a one year low of $461.05 and a one year high of $727.25. The stock has a market capitalization of $27.50 billion, a price-to-earnings ratio of 40.543 and a beta of 0.72.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.97 by $0.65. The business had revenue of $670 million for the quarter, compared to analyst estimates of $640.69 million. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. During the same period in the prior year, the firm earned $4.57 earnings per share. On average, equities analysts predict that Intuitive Surgical will post $21.30 earnings per share for the current year.

In related news, CFO Marshall Mohr sold 5,000 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $684.09, for a total value of $3,420,450.00. Following the transaction, the chief financial officer now directly owns 6,725 shares of the company’s stock, valued at $4,600,505.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Curet Myriam sold 4,250 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $684.39, for a total transaction of $2,908,657.50. Following the completion of the transaction, the senior vice president now directly owns 3,133 shares in the company, valued at $2,144,193.87. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Acropolis Investment Management LLC bought a new position in shares of Intuitive Surgical during the third quarter worth about $109,000. Global X Management Co. LLC bought a new position in shares of Intuitive Surgical during the second quarter worth about $118,000. Acrospire Investment Management LLC bought a new position in shares of Intuitive Surgical during the first quarter worth about $120,000. Bartlett & Co. LLC increased its position in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares during the last quarter. Finally, Glenmede Trust Co. NA increased its position in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares during the last quarter. 91.90% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.